Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Flexor Tendon Trial
ACTRN12618000019202Phase 4Recruiting
- Sponsor
- Gold Coast Hospital and Health Service
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ibuprofen in Hand tendon injury (2 arms), sponsored by Gold Coast Hospital and Health Service. Primary endpoints: Range of motion by Strickland criteria, Total active motion by ASSH criteria and 2 more. Started May 2018; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
Hand tendon injury
Beyond the preview
Go deeper on ACTRN12618000019202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000019202.